US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Change in Terveystalo's Executive Team: Sari Heinonen to a new position outside the company

Terveystalo Plc stock exchange release 15 January 2025 at 14:50 EET Sari Heinonen, member of Terveystalo's Executive Team and Executive Vice President, Healthcare Services, has announced that she will leave the company on 15 April 2025 to move to a new position as President of LocalTapiola Group. Terveystalo will announce Heinonen's successor at a later date. -I extend my sincere gratitude to Sari and wish her continued success in her new role. Under Sari's leadership, a robust development agenda has been established for Healthcare Services, and a challenging profit improvement

Proposals of the Shareholders' Nomination Board of Terveystalo for the Annual General Meeting 2025

Terveystalo Plc Stock Exchange Release 13 December 2024 at 10:15 EET The Shareholders' Nomination Board of Terveystalo has submitted to the Board of Directors its proposals for the Annual General Meeting 2025. Proposal on the number of members of the Board of Directors and its composition The Shareholders' Nomination Board proposes to the Annual General Meeting that the number of members of the Board of Directors shall be seven (7). The Shareholders' Nomination Board proposes, for a term that ends at the end of the Annual General Meeting 2026, that Kari Kauniskangas, Sofia

Terveystalo's Capital Markets Day 2024

Terveystalo Plc’s Press Release on 4 December 2024 at 8:00 a.m. EET  Terveystalo hosts its Capital Markets Day 2024 today in Helsinki. The event takes place at 10:00 a.m. EET at Hobo Hotel, Kluuvikatu 4, 00100 Helsinki, and is also available online. The live webcast starts at 10:30 a.m. EET and concludes at approximately 2:30 p.m.  The event provides updates on Terveystalo’s operating environment, strategy, and capital allocation priorities. Presentations will be delivered by President and CEO Ville Iho, CFO Juuso Pajunen, and other members of the Executive team.   The presentation

Terveystalo updates its medium-term financial targets

Terveystalo Oyj, Stock Exchange Release, 2 December 2024 at 08:00 (EET) Terveystalo’s Board of Directors has approved the company’s updated financial targets and dividend policy for the medium term. All targets have been updated to reflect the company's improved performance and focus on value creation. Terveystalo’s updated financial targets and dividend policy are as follows: Profitable growth: · EPS to grow on average by 10% p.a. · We expect faster earnings per share growth in 2025, as fewer items affecting comparability are expected Moderate leverage ratio: · Net

Inside information: Profit warning - Terveystalo raises its profitability guidance for 2024

Terveystalo Plc, inside information 25 November 2024 at 08:00 EEST  Terveystalo raises its profitability guidance for 2024.  The guidance for revenue remains unchanged. “In quarter performance so far has been stronger than our forecasts, thanks to a strong demand and further improved operational efficiency. Our earnings improvement continues, and we forecast full-year 2024 adjusted EBITA margin to be 12.5-13.1%," commented Ville Iho, President and CEO of Terveystalo. New guidance for 2024: Terveystalo expects its full-year 2024 revenue to grow (2023: EUR 1,286 million) and

Invitation to Terveystalo's Capital Markets Day 2024

Terveystalo Plc’s Press Release on 4 November 2024 at 12:00 EET  Terveystalo invites analysts, institutional investors, and other capital market representatives to its Capital Markets Day 2024. The event will take place on the 4th of December at 10:00 a.m. EET at Hobo Hotel, Kluuvikatu 4, 00100 Helsinki, and will also be available online. The live webcast is scheduled to commence at 10:30 a.m. EET and conclude at approximately 3:15 p.m.  The event will provide updates on Terveystalo’s operating environment, strategy, and capital allocation priorities. Presentations will be delivered

Terveystalo Plc: Managers’ Transactions (Kauniskangas)

Terveystalo Plc, Managers’ transactions, 1 November 2024 at 14:00 EET On 26 March 2024, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Hasselberg)

Terveystalo Plc, Managers’ transactions, 1 November 2024 at 14:00 EET On 26 March 2024, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Lehtoranta)

Terveystalo Plc, Managers’ transactions, 1 November 2024 at 14:00 EET On 26 March 2024, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Lemne)

Terveystalo Plc, Managers’ transactions, 1 November 2024 at 14:00 EET On 26 March 2024, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Pullola)

Terveystalo Plc, Managers’ transactions, 1 November 2024 at 14:00 EET On 26 March 2024, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Rosenberg)

Terveystalo Plc, Managers’ transactions, 1 November 2024 at 14:00 EET On 26 March 2024, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Sarajärvi)

Terveystalo Plc, Managers’ transactions, 1 November 2024 at 14:00 EET On 26 March 2024, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo's financial reporting and Annual General Meeting in 2025

Terveystalo Plc, Stock Exchange Release, Financial Calendar, 25 October 2025 at 09:15 EEST In 2025, Terveystalo will publish financial information as follows: Financial statements release 2024                                        14 February 2025Annual Report 2024                                                                Week 11Interim Report, 1 January – 31 March, 2025                          25 April 2025Half-yearly Report, 1 January – 30 June, 2025                      17 July 2025Interim Report, 1 January – 30 September, 2025                   23 October 2025

Petteri Lankinen appointed Terveystalo's Chief Medical Officer and member of the Executive Team

Terveystalo Plc stock exchange release 25 October 2024 at 9.05 a.m. EEST Petteri Lankinen, born in 1981, Doctor of Medical Science, eMBA, has been appointed as Terveystalo's Chief Medical Officer and member of the Executive Team. He will take up his position on 25 January 2025 at the latest. Dr. Lankinen is a licensed specialist and an adjunct professor in orthopaedics and traumatology. He will report directly to CEO Ville Iho. Dr. Lankinen transitions to this new role from his position as Chief Medical Officer and Senior Partner at Nordic Healthcare Group, a consultancy firm, where he

Terveystalo Group Interim Report January–September 2024: Strong earnings growth driven by improved operational efficiency

Terveystalo Plc, Interim Report, 25 October 2024 at 09:00 EEST This release is a summary of Terveystalo's Interim Report for January–September 2024. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/company/investors/reports-and-presentations/July–September 2024 in brief · Revenue increased by 5.4 percent year-on-year to EUR 295.8 (280.5) million.Q3 had one more working day vs. the comparison period.The Healthcare Services segment revenue increased by 10.8 percent and was EUR 232.0 (209.3) million.

Terveystalo Q3/ 2024 result webcast and conference call on 25 October 2024

Terveystalo Press Release, 10 October 2024 Terveystalo Plc will publish its Interim Report for January-September 2024 on Friday 25 October 2024 at 9:00 EEST. Materials will be available soon after publication on Terveystalo’s IR website. Terveystalo will arrange a result webcast and conference call in English on the same day, starting at 10:30 EEST. You can watch the webcast online at: https://terveystalo.videosync.fi/q3-2024 Conference call:You can access the teleconference by registering on the link below. After the registration you will be provided phone numbers and a

Composition of Terveystalo Plc's shareholders' nomination board

Terveystalo Plc Stock Exchange Release 27 September 2024 at 12:45 EEST The Shareholders' Nomination Board of Terveystalo Plc comprises the representatives of the four largest shareholders of the company as of 2 September 2024 and, in addition, the Chairman of the Board of Directors. If a shareholder refrains from exercising their right to appoint a proxy, the right of appointment shall pass to the next largest shareholder in the list of shareholders. The duties of the Nomination Board include, for example, the search, preparation, and presentation of member candidates for the Board of

Terveystalo acquires Cityläkarna in Åland

Terveystalo Press Release 6 September 2024   Terveystalo is expanding its services in Åland by acquiring Cityläkarna Mariehamn Ab in Åland through a share deal. Established in 1990, the medical centre provides general and specialist medical services, psychology services and physiotherapy to occupational health and private customers. The company has one clinic in Mariehamn. The company employs around 30 professionals and its revenue in 2023 was approximately EUR 3 million. " The transaction will provide our staff and professionals with work and development opportunities in a

Change in Terveystalo's Executive Team: Chief Medical Officer Petri Bono leaves the company

Terveystalo Plc, stock exchange release 6 August 2024 at 9:00 a.m. EEST   Petri Bono, who has served as Terveystalo's Chief Medical Officer and member of the Executive Team since 2019, has announced that he will leave the company on 14 August 2024 to take up a new position outside the company.   -          Under Petri's leadership, a strong team has been built in the medical management and our quality is among the best in the industry. I warmly thank Petri for his excellent work, for example, in managing the challenging coronavirus years and taking our medical management

Terveystalo Group Half-Year Report January–June 2024: Strong and rapid progress towards the financial targets

Terveystalo Plc, Half-Year Report 17 July, 2024 at 09:00 EEST This release is a summary of Terveystalo's Half-Year Report 2024. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/company/investors/reports-and-presentations/ April–June 2024 in brief · Revenue increased by 5.5 percent year-on-year to EUR 340.1 (322.4) million.Q2 had one more working day vs. the comparison period.The Healthcare Services segment revenue increased by 11.4 percent and was EUR 261.4 (234.7) million. Portfolio Businesses

Inside information: Profit warning - Terveystalo raises its profitability guidance for 2024 and provides preliminary information on revenue and profitability for the second quarter of 2024

Terveystalo Plc, inside information 11 July 2024 at 08:00 EEST The implementation of Terveystalo's profit improvement program has progressed faster during the first half of the year than originally expected, and Terveystalo raises its profitability guidance for 2024.  The guidance for revenue remains unchanged. - Our profit improvement measures have had a faster impact than expected and our profitability strengthened even during the seasonally lower demand in the summer. The fifth consecutive quarter of profit improvement and Q2 results underline that the turnaround objectives set

Terveystalo Plc: Flagging announcement in accordance with Chapter 9, Section 10 of the Securities Markets Act

Terveystalo Oyj, Stock Exchange Release 28 June 2024 at 14:30 EEST Terveystalo Plc has on 28 June 2024 received a notification under Chapter 9, Section 5 of the Securities Market Act, according to which the holding of Rettig Investment AB in Terveystalo Plc’s shares and votes has risen above 15 per cent on 27 June 2024. The holding of Rettig Investment AB has increased to 16.65 per cent and 21,153,191 shares of the total of Terveystalo's shares and votes. Terveystalo has a total of 127 036 531 shares. Each share entitles its holder to one (1) vote. Total positions of Rettig

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe

Media